Serum lipidomics for exploring biomarkers of bortezomib therapy in patients with multiple myeloma.

Cancer Sci · 2019 · PMC6778623 · PMID 31444836

Europe PMC DOI

hedged sentences

0.0095

closest p · 0.2× alpha

0.0095

boldest claim

The sentences

showed a trendP = .0095actually significant

There were no differences in the total cholesterol and triglyceride levels and hemoglobin concentrations between responders and nonresponders, whereas serum albumin levels showed a trend towards decrease ( P = .0095, not significant) in nonresponders.

also in 53,322 other papers

borderline significantno p-value reported

In addition, other LPCs, such as LPC(17:1) ( P = .0058), LPC(18:1e) ( P = .0055), and LPC(20:5) ( P = .0087), showed borderline significant association.

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.